Pentasa and Sneezing - a phase IV clinical study of FDA data

Summary:

Sneezing is reported as a side effect among people who take Pentasa (mesalamine), especially for people who are female, 60+ old, also take Humira, and have Osteoporosis.

The phase IV clinical study analyzes which people have Sneezing when taking Pentasa. It is created by eHealthMe based on reports of 22,797 people who have side effects when taking Pentasa from the FDA, and is updated regularly.

What is Pentasa?

Pentasa has active ingredients of mesalamine. It is often used in crohn's disease. eHealthMe is studying from 23,325 Pentasa users. Check the latest studies of Pentasa.

What is Sneezing?

Sneezing is found to be associated with 1,069 drugs and 1,266 conditions by eHealthMe. Check the latest studies of Sneezing.

On Aug, 07, 2026

22,797 people reported to have side effects when taking Pentasa.
Among them, 44 people (0.19%) have Sneezing.

Among these 44 people:

What is the gender of people who have Sneezing when taking Pentasa? *

female: 75.68 %
male: 24.32 %

What is the age of people who have Sneezing when taking Pentasa? *

What are other drugs people take besides Pentasa? *

What are other side effects people have besides Sneezing? *

Nasopharyngitis (inflammation of the nasopharynx): 24 people, 54.55%
Rhinorrhea (watery mucus discharge from the nose): 20 people, 45.45%
Cough: 19 people, 43.18%
Fatigue (feeling of tiredness): 13 people, 29.55%
Joint Pain: 11 people, 25.00%
Sleep Apnea Syndrome: 11 people, 25.00%
Weight Increased: 11 people, 25.00%
Drug Ineffective: 11 people, 25.00%
Oropharyngeal Pain: 11 people, 25.00%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 10 people, 22.73%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 5 people, 11.36%
Upper Respiratory Tract Infection: 2 people, 4.55%
Diarrhea: 2 people, 4.55%
High Blood Pressure: 2 people, 4.55%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 4.55%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 4.55%
Pain: 2 people, 4.55%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 4.55%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 1 person, 2.27%
Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 1 person, 2.27%

* Approximation only. Some reports may have incomplete information.

Do you take Pentasa and have Sneezing?

- Check whether Sneezing is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pentasa:

Pentasa (23,325 reports)

Sneezing treatments and more:

Sneezing (27,798 reports)

Browse all side effects of Pentasa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sneezing:

Sneezing (1,069 drugs)

Browse all the conditions that are associated with Sneezing:

Sneezing (1,266 conditions)

Related publications that referenced our studies

Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on mesalamine (the active ingredients of Pentasa) and Pentasa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.